Signaling Pathways for UV-Induced Melanogenic Responses
Signaling Pathways for UV-Induced Melanogenic Responses
批准号:
6889305
负责人:
ZALFA ABDEL-MALEK
金额:
$32.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2008-03-31
关键词:
DNA damageDNA repairJUN kinaseapoptosisbiological signal transductioncAMP response element binding proteinclinical researchendothelinhormone regulation /control mechanismhuman subjecthuman tissuemelaninsmelanocytemelanocyte stimulating hormonemitogen activated protein kinasenuclear factor kappa betaradiation geneticsserine threonine protein kinasetissue /cell culturetranscription factorultraviolet radiationwestern blottings
中文摘要
描述(申请人提供):在人类皮肤中,表皮黑素细胞主要由于其合成黑色素的能力而在光保护中发挥关键作用。黑素细胞的增殖能力极低,因此它们在表皮中的存活对皮肤的光保护至关重要。然而,越来越清楚的是,皮肤癌的风险不仅仅取决于皮肤中的黑色素含量,还取决于元细胞在紫外线照射下保持基因组稳定的能力,以防止恶性转化为黑色素瘤。内皮素-1(ET-1)和α-黑素细胞刺激素(α-MSH)是两种受紫外线照射刺激合成的表皮因子。这两种因素都能使人类黑素细胞克服紫外线诱导的G1期停滞,并刺激黑素生成。最近,我们发现ET-1和APHA-MSH通过抑制黑素细胞的凋亡来增加紫外线照射后黑素细胞的存活率。我们发现,培养的人类黑素细胞在黑素皮质素1受体(α-MSH的受体)中表达功能丧失突变,增加了对UVR杀伤的敏感性。我们将这种敏感性的增加归因于紫外线照射导致的广泛DNA损伤,使这些细胞的修复能力不堪重负,以及无法完全激活生存途径。这些突变与晒黑能力差以及患黑色素瘤和非黑色素瘤皮肤癌的风险增加有关,与皮肤或头发的颜色无关。我们假设ET-1和α-MSH通过抑制细胞凋亡和减少UVB诱导的DNA损伤程度来促进人类黑素细胞的存活。我们建议研究ET-1和/或α-MSH限制UVB诱导的DNA损伤和/或提高DNA修复速度的能力。我们还将确定ET-1和α-MSH激活Akt/PKB依赖的生存途径的能力。已知激活的Akt/PKB通过磷酸化和失活其底物Bad和caspase 9,以及激活NFkB和CREB来抑制细胞凋亡。此外,我们计划阐明ET-1和/或α-MSH的生存效应是否涉及转录因子MITF的激活,MITF通过调节UVB照射的黑素细胞中ERK1/2、p38和JNK/SAPK以及CREB的活性来上调Bcl2的表达。确定不同色素表型的黑素细胞对生存因子的反应能力的差异,对于评估UVR对皮肤的细胞毒性和遗传毒性效应的大小具有重要意义。此外,评估a-MSH和ET-1对生存影响的不同敏感性可以作为确定皮肤癌,特别是黑色素瘤个体风险的可靠标志。
英文摘要
DESCRIPTION (provided by applicant): In human skin, epidermal melanocytes play a crucial role in photoprotection mainly due to their ability to synthesize melanin. Melanocytes have an extremely low proliferative capacity, thus their survival in the epidermis is crucial for cutaneous photoprotection. However, it is becoming clear that the risk for skin cancer is not simply determined by melanin content in the skin, but rather by the ability of the metanocyte to maintain genomic stability in the face of exposure to ultraviolet radiation, to prevent malignant transformation into melanoma. Endothelin-1 (ET-1) and alpha-melanocyte stimulating hormone (alpha-MSH) are two epidermal factors whose synthesis is stimulated by UV exposure. Both factors enable human melanocytes to overcome UV-induced G1 arrest and stimulate melanogenesis. Recently, we demonstrated that ET-1 and apha-MSH increase the survival of UV-irradiated melanocytes by inhibiting apoptosis. We found that cultured human melanocytes that express loss-of-function mutations in the melanocortin 1 receptor, the receptor for alpha-MSH, have increased susceptibility to killing by UVR. We attribute this increased sensitivity to UV exposure to extensive DNA damage that overwhelms the repair capacity of those cells, and to inability to fully activate survival pathways. These mutations have been associated with poor tanning ability, and increased risk for melanoma and non-melanoma skin cancers, independently of skin or hair color. We hypothesize that ET- 1 and alpha-MSH promote human melanocyte survival by inhibiting apoptosis and reducing the extent of UVB-induced DNA damage. We propose to investigate the ability of ET-1 and/or a-MSH to limit the extent of UVB-induced DNA damage and/or to enhance the rate of DNA repair. We will also determine the capacity of ET-1 and alpha-MSH to activate the Akt/PKBdependent survival pathway. Activated Akt/PKB is known to inhibit apoptosis by phosphorylating and inactivating its substrates Bad and caspase 9, and by activating NFkB and CREB. Additionally, we plan to elucidate whether the survival effects of ET-1 and/or alpha-MSH involve activation of the transcription factor Mitf, which upregulates Bcl2 expression, by modulating the activities of ERK1/2, p38 and JNK/SAPK, and CREB in UVB-irradiated melanocytes. Determining the differences in the ability of melanocytes from different pigmentary phenotypes to respond to survival factors is significant for assessing the magnitude of the cytotoxic and genotoxic effects of UVR in the skin. Also, assessing the differential sensitivity to the survival effects of a-MSH and ET-1 can be used as a reliable marker for determining individual risk to skin cancer, particularly melanoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vitiligo topical treatment applying a potent, highly selective MC1R agonist
-
批准号:10759768
-
项目类别:
-
资助金额:$29.59万
-
财政年份:2023
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
-
批准号:10474302
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
-
批准号:10265379
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
-
批准号:9898307
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Melanoma prevention by MC1R selective small peptide analogs of alpha MSH
-
批准号:9105353
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2015
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Melanoma prevention by MC1R selective small peptide analogs of alpha MSH
-
批准号:8958319
-
项目类别:
-
资助金额:$22.16万
-
财政年份:2015
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
How p16 and MC1R mutations synergistically exacerbate melanoma risk.
-
批准号:8652005
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2014
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
-
批准号:7730250
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2009
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
-
批准号:8462256
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2009
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Signaling Pathways for UV-Induced Melanogenic Response
-
批准号:7902757
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2009
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
-
批准号:8274543
-
项目类别:
-
资助金额:$32.46万
-
财政年份:2009
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
-
批准号:8069824
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2009
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
-
批准号:7495746
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2006
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
-
批准号:7294334
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2006
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
-
批准号:7198365
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2006
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
-
批准号:7683752
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2006
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
19th International Pigment Cell Conference - 2005
-
批准号:7000810
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2005
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
Arsenic induced signaling pathways in human epidermis
-
批准号:6578779
-
项目类别:
-
资助金额:$17.11万
-
财政年份:2002
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
SIGNALING PATHWAYS FOR UV-INDUCED MELANOGENIC RESPONSE
-
批准号:2900433
-
项目类别:
-
资助金额:$18.02万
-
财政年份:1998
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
SIGNALING PATHWAYS FOR UV-INDUCED MELANOGENIC RESPONSE
-
批准号:6605371
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1998
-
负责人:ZALFA ABDEL-MALEK
-
依托单位:
海外基金